Epimedium-derived phytoestrogen flavonoids exert beneficial effect on preventing bone loss in late postmenopausal women: A 24-month randomized, double-blind and placebo-controlled trial
Publication in refereed journal


Times Cited
Web of Science159WOS source URL (as at 07/08/2020) Click here for the latest count
Altmetrics Information
.

Other information
AbstractEpimedium brevicornum maxim, a nonleguminous medicinal plant, has been found to be rich in phytoestrogen flavonoids. Results from a 24-month randomized double-blind placebo-controlled clinical trial showed that Epimedium-derived phytoestrogen flavonoids were able to exert beneficial effects on preventing bone loss in late postmenopausal women, without resulting in a detectable hyperplasia effect on the endometrium.
All Author(s) ListZhang G, Qin L, Shi YY
Journal nameJournal of Bone and Mineral Research
Detailed descriptionPMID: 17419678 .
Year2007
Month7
Day1
Volume Number22
Issue Number7
PublisherAMER SOC BONE & MINERAL RES
Pages1072 - 1079
ISSN0884-0431
eISSN1523-4681
LanguagesEnglish-United Kingdom
Keywordsbone loss; Epimedium brevicornum maxim; late postmenopausal women; nonleguminous medicinal plant; phytoestrogen flavonoids
Web of Science Subject CategoriesEndocrinology & Metabolism; ENDOCRINOLOGY & METABOLISM

Last updated on 2020-08-08 at 01:16